Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Yim, D, Curtis, N, Cheung, M, Burgner, D.
An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes..
J Paediatr Child Health
49(8)
:
614 -623
2013
view publication
Golshevsky, D, Cheung, M, Burgner, D.
Kawasaki disease--the importance of prompt recognition and early referral..
Aust Fam Physician
42(7)
:
473 -476
2013
view publication
Strunk, T, Jamieson, SE, Burgner, D.
Genetic and epigenetic susceptibility to early life infection..
Curr Opin Infect Dis
26(3)
:
241 -247
2013
view publication
Sun, C, Burgner, DP, Ponsonby, A-L, Saffery, R, Huang, R-C, Vuillermin, PJ, Cheung, M, Craig, JM.
Effects of early-life environment and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies..
Pediatr Res
73(4 Pt 2)
:
523 -530
2013
view publication